Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients

Acta Tropica

Volumn 92, Issue 2, 2004, Pages 127-132

  Amato, Valdir S ^a   Rabello, Ana ^b   Rotondo Silva, Alexandre ^b   Kono, Adriana ^a   Maldonado, Tânia Patrícia H ^a   Alves, Isabel C ^c   Floeter Winter, Lucile M ^c   Neto, Vicente Amato ^a   Shikanai Yasuda, Maria Aparecida ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Department of Parasitology   (Brazil)

Author keywords

American tegumentary leishmaniasis; Cutaneous leishmaniasis; Human immunodeficiency virus; Leishmaniasis; Lipid formulations of amphotericin B

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; COTRIMOXAZOLE; DIPYRIDAMOLE; DIPYRONE; EFAVIRENZ; ENALAPRIL; FUROSEMIDE; LAMIVUDINE; MEGLUMINE ANTIMONATE; MEVINOLIN; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; STAVUDINE; TACROLIMUS; VITAMIN;

LEISHMANIASIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COLLOID; DIABETES MELLITUS; DIALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; HEALING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; KIDNEY FAILURE; LABORATORY TEST; LEISHMANIA; LOW BACK PAIN; MALE; MICROSCOPY; SIDE EFFECT; SKIN LEISHMANIASIS; SKIN TEST; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; DRUG COMBINATIONS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY FAILURE, CHRONIC; LEISHMANIASIS, CUTANEOUS; LIPOSOMES; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 4444356704     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2004.06.006     Document Type: Article

References (21)

1. J. Alvar, C. Canavate, B. Gutierrez-Solar, F. Laguna, R. Lopez-Velez, R. Molina, and J. Moreno Leishmania and human immunodeficiency virus coinfection: the first 10 years Clin. Microbiol. Rev. 10 1997 298 319
2. C.R. Alving Delivery of liposome-encapsulated drugs to macrophages Pharmacotherapy 22 1983 407 424
3. V.S. Amato, A.C. Nicodemo, J.G. Amato, M. Boulos, and V.A. Neto Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome) J. Antimicrob. Chemother. 46 2000 341 342
4. J.D. Berman Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years Clin. Infect. Dis. 24 1997 684 703
5. T.M. Castilho, J.J. Shaw, and L.M. Floeter-Winter New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species J. Clin. Microbiol. 41 2003 540 546
6. J.R. Coura, B. Galvão-Castro, and G. Grimaldi Jr. Disseminated American cutaneous leishmaniasis in a patient with AIDS Mem. Inst. Oswaldo Cruz. Rio. de. Janeiro 82 2003 581 582
7. R. Dietze, E.P. Milan, and J.D. Berman Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion) Clin. Infect. Dis. 17 1993 981 986
8. G. Grimaldi Jr., R.B. Tesh, and D. McMahon-Pratt A review of the geographic distribuition and epidemiology of leishmaniasis in the new world Am. J. Trop. Med. Hyg. 41 1989 687 725
9. D.E. Hernández, M. Oliver, C. Martinez, and G. Planas Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS) Int. J. Dermatol. 34 1995 114 115
10. A. Krolewiecki, S. Leon, P. Scott, and D. Abraham Activity of azithromycin against Leishmania major in vitro and in vivo Am. J. Trop. Med. Hyg. 67 2002 273 277
11. R. Martino Efficacy, safety and cost-effectiveness of Amphotericin B lipid complex (ABLC): a review of the literature Curr. Med. Res. Opin. 20 2004 485 504
12. M.C.A. Marzochi, and K.B.F. Marzochi Tegumentary and visceral Leishmaniases in Brazil - emerging anthropozoonosis and possibilities for their control Cad. Saude Publ. 10 2 1994 360 375
13. M. Mattos, A. Caiza, O. Fernandes, A.J.S. Gonç;alves, C. Pirmez, C.S.F. Souza, and M.P. Oliveira-Neto American cutaneous leishmaniasis associated with HIV infection: report of four cases J. Eur. Acad. Dermatol. Venereol. 10 1998 218 225
14. A. Prata, M.L. Silva-Vergara, L. Costa, A. Rocha, A. Krolewiecki, J.C. Silva, E.V. de Paula, F.G. Pimenta Junior, and L.E. Giraldo Efficacy of azithromycin in the treatment of cutaneous leishmaniasis Rev. Soc. Bras. Med. Trop. 36 2003 65 69
15. A. Rabello, M. Orsini, and J. Disch Leishmania/HIV co-infection in Brazil: an appraisal Ann. Trop. Med. Parasitol. 97 1 2003 17 28
16. C. Rapp, P. Imbert, H. Darie, F. Simon, P. Gros, T. Debord, and R. Roue Lipossomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate Bull. Soc. Pathol. Exot. 96 2003 209 211
17. G.A.S. Romero, M.V.F. Guerra, M.G. Paes, and V.O. Macêdo Comparison of cutaneous leishmaniasis due to Leishmania(Viannia)braziliensis and L (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate Am. J. Trop. Med. Hyg. 65 2001 456 465
18. I.S.S. Souza, R.D. Naiff, T.C. Guimarães, M.F. Naiff, E. Cupolillo, W.A. Rodrigues, and A.P.M. Schettini American cutaneous leishmaniasis due to Leishmania(Viannia)guyanensis as an initial clinical presentation of human immunodeficiency virus infection J. Eur. Acad. Dermatol. Venereol. 10 1998 214 217
19. J. Torre-Cisneros, J.L. Prada, J.L. Villanueva, F. Valverde, and P. Sánchez-Guijó Successful treatment of antimony-resistent cutaneous leishmaniasis with lipossomal amphotericin B Clin. Infect. Dis. 18 1994 1024 1025
20. G.W. Wortmann, S.L. Fraser, N.E. Aronson, C. Davis, R.S. Miller, J.D. Jackson, and C. Oster Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis Clin. Infect. Dis. 26 1998 1006 1007
21. V. Yardley, and S.L. Croft A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis Int. J. Antimicrob. Agents 13 2000 243 248